220 related articles for article (PubMed ID: 23403885)
21. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
[TBL] [Abstract][Full Text] [Related]
22. Integrative computational analysis of transcriptional and epigenetic alterations implicates DTX1 as a putative tumor suppressor gene in HNSCC.
Gaykalova DA; Zizkova V; Guo T; Tiscareno I; Wei Y; Vatapalli R; Hennessey PT; Ahn J; Danilova L; Khan Z; Bishop JA; Gutkind JS; Koch WM; Westra WH; Fertig EJ; Ochs MF; Califano JA
Oncotarget; 2017 Feb; 8(9):15349-15363. PubMed ID: 28146432
[TBL] [Abstract][Full Text] [Related]
23. Inactivation of the tumor suppressor genes causing the hereditary syndromes predisposing to head and neck cancer via promoter hypermethylation in sporadic head and neck cancers.
Smith IM; Mithani SK; Mydlarz WK; Chang SS; Califano JA
ORL J Otorhinolaryngol Relat Spec; 2010; 72(1):44-50. PubMed ID: 20332657
[TBL] [Abstract][Full Text] [Related]
24. PHF21B as a candidate tumor suppressor gene in head and neck squamous cell carcinomas.
Bertonha FB; Barros Filho Mde C; Kuasne H; Dos Reis PP; da Costa Prando E; Muñoz JJ; Roffé M; Hajj GN; Kowalski LP; Rainho CA; Rogatto SR
Mol Oncol; 2015 Feb; 9(2):450-62. PubMed ID: 25454821
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA
Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258
[TBL] [Abstract][Full Text] [Related]
26. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype.
Sengupta S; Chakrabarti S; Roy A; Panda CK; Roychoudhury S
Cancer; 2007 Feb; 109(4):703-12. PubMed ID: 17219447
[TBL] [Abstract][Full Text] [Related]
27. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
[TBL] [Abstract][Full Text] [Related]
28. Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer.
Guerrero-Preston R; Michailidi C; Marchionni L; Pickering CR; Frederick MJ; Myers JN; Yegnasubramanian S; Hadar T; Noordhuis MG; Zizkova V; Fertig E; Agrawal N; Westra W; Koch W; Califano J; Velculescu VE; Sidransky D
Epigenetics; 2014 Jul; 9(7):1031-46. PubMed ID: 24786473
[TBL] [Abstract][Full Text] [Related]
29. DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage.
Smith IM; Mydlarz WK; Mithani SK; Califano JA
Int J Cancer; 2007 Oct; 121(8):1724-8. PubMed ID: 17582607
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma.
Cao W; Zhang ZY; Xu Q; Sun Q; Yan M; Zhang J; Zhang P; Han ZG; Chen WT
Mol Cancer; 2010 Nov; 9():296. PubMed ID: 21092172
[TBL] [Abstract][Full Text] [Related]
31. Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer.
Sun W; Zaboli D; Wang H; Liu Y; Arnaoutakis D; Khan T; Khan Z; Koch WM; Califano JA
Clin Cancer Res; 2012 Feb; 18(4):1082-91. PubMed ID: 22228635
[TBL] [Abstract][Full Text] [Related]
32. Pharmacologic unmasking of epigenetically silenced genes in breast cancer.
Ostrow KL; Park HL; Hoque MO; Kim MS; Liu J; Argani P; Westra W; Van Criekinge W; Sidransky D
Clin Cancer Res; 2009 Feb; 15(4):1184-91. PubMed ID: 19228724
[TBL] [Abstract][Full Text] [Related]
33. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance.
Carvalho AL; Henrique R; Jeronimo C; Nayak CS; Reddy AN; Hoque MO; Chang S; Brait M; Jiang WW; Kim MM; Claybourne Q; Goldenberg D; Khan Z; Khan T; Westra WH; Sidransky D; Koch W; Califano JA
Clin Cancer Res; 2011 Jul; 17(14):4782-9. PubMed ID: 21628494
[TBL] [Abstract][Full Text] [Related]
34. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
[TBL] [Abstract][Full Text] [Related]
35. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
[TBL] [Abstract][Full Text] [Related]
36. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic inactivation of RASSF1A in head and neck cancer.
Dong SM; Sun DI; Benoit NE; Kuzmin I; Lerman MI; Sidransky D
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3635-40. PubMed ID: 14506151
[TBL] [Abstract][Full Text] [Related]
38. Expression microarray analysis reveals alternative splicing of LAMA3 and DST genes in head and neck squamous cell carcinoma.
Li R; Ochs MF; Ahn SM; Hennessey P; Tan M; Soudry E; Gaykalova DA; Uemura M; Brait M; Shao C; Westra W; Bishop J; Fertig EJ; Califano JA
PLoS One; 2014; 9(3):e91263. PubMed ID: 24675808
[TBL] [Abstract][Full Text] [Related]
39. Altered DNA methylation is associated with aberrant stemness gene expression in early‑stage HNSCC.
Suzuki T; Yamazaki H; Honda K; Ryo E; Kaneko A; Ota Y; Mori T
Int J Oncol; 2019 Oct; 55(4):915-924. PubMed ID: 31432153
[TBL] [Abstract][Full Text] [Related]
40. EIF2C is overexpressed and amplified in head and neck squamous cell carcinoma.
Chang SS; Smith I; Glazer C; Hennessey P; Califano JA
ORL J Otorhinolaryngol Relat Spec; 2010; 72(6):337-43. PubMed ID: 20924207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]